|
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer |
47.71 |
|
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 |
47.23 |
|
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] |
47.23 |
|
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) |
36.36 |
|
RNA sequencing of mechanically strained NHEKs and control NHEKs |
35.75 |
|
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state |
34.41 |
|
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile |
30.59 |
|
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] |
30.59 |
|
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs |
28.39 |
|
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation |
26.76 |
|
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons |
25.61 |
|
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing |
23.1 |
|
miRNAs affected by antagomiR-17 treatment |
23.04 |
|
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity |
21.99 |
|
RNAseq Analysis in glioblastoma cells treated with Mepazine |
21.98 |
|
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition |
21.86 |
|
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) |
21.86 |
|
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] |
21.05 |
|
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] |
20.91 |
|
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] |
20.78 |
|
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation |
20.78 |
|
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells |
20.41 |
|
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway |
20.33 |
|
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD |
19.94 |
|
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control |
19.84 |
|
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis |
19.16 |
|
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] |
18.78 |
|
Selective suppression of endothelial cytokine production by progesterone receptor |
18.78 |
|
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes |
18.31 |
|
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D |
18.15 |
|
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells |
17.99 |
|
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages |
17.98 |
|
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) |
17.97 |
|
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown |
17.9 |
|
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) |
17.9 |
|
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) |
17.72 |
|
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes |
17.72 |
|
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia |
17.61 |
|
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism |
17.51 |
|
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine |
17.34 |
|
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis |
17.19 |
|
Ebola virus (EBOV) infection of ARPE-19 cells |
17.0 |
|
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors |
16.94 |
|
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. |
16.91 |
|
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. |
16.8 |
|
Knockdown of ADNP in HCT116 colon cancer cells |
16.65 |
|
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] |
16.14 |
|
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles |
15.98 |
|
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media |
15.95 |
|
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] |
15.9 |
|
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer |
15.9 |
|
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture |
15.41 |
|
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells |
15.33 |
|
IGF2BP3 controls cancer cell invasiveness by modulation RISC function |
15.07 |
|
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression |
15.03 |
|
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis |
14.65 |
|
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression |
14.58 |
|
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness |
14.56 |
|
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line |
14.41 |
|
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] |
14.41 |
|
RNA sequencing of GlyH-101-treated MCF-7 cell line |
14.31 |
|
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') |
14.25 |
|
Identifying the molecular mode of action of itraconazole in colorectal cancer |
14.19 |
|
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity |
14.18 |
|
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells |
14.12 |
|
Human neutrophil genome during PMA- and E. coli encounter-induced activation |
14.1 |
|
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation |
14.1 |
|
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation |
13.99 |
|
Transcriptomic Profiling of Developing Human Paraxial Mesoderm from 4.5-5 Weeks of Gestation Human Embryos |
13.8 |
|
RNA-seq of naive and primed ES cells |
13.76 |
|
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] |
13.55 |
|
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) |
13.54 |
|
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption |
13.53 |
|
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells |
13.51 |
|
RNA-seq of young and quiescent MRC-5 human fibroblasts |
13.51 |
|
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples |
13.44 |
|
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion |
13.43 |
|
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma |
13.19 |
|
The interplay between SOX4 and SMAD3 in the context of breast cancer |
13.17 |
|
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias |
13.17 |
|
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells |
13.14 |
|
Tracing Enhancer Networks using Epigenetic Traits (TENET) |
12.98 |
|
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells |
12.77 |
|
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis |
12.66 |
|
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia |
12.64 |
|
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO |
12.54 |
|
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells |
12.44 |
|
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) |
12.33 |
|
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress |
12.32 |
|
Genetic-to-epigenetic Therapy for Pancreatic Cancer |
12.2 |
|
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] |
12.16 |
|
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine |
12.16 |
|
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis |
11.97 |
|
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression |
11.96 |
|
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] |
11.96 |
|
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells |
11.92 |
|
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] |
11.9 |
|
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid during virologically suppressed HIV |
11.85 |
|
An siRNA screen identifies CHD4 as a target for epigenetic therapy |
11.84 |
|
Impact of dieldrin on transcription in Jurkat T cells |
11.79 |
|
RNAseq analysis of ESRP regulated splicing events in prostate cancer |
11.73 |
|
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine |
11.72 |
|
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs |
11.66 |
|
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells |
11.65 |
|
Human HAP1 cells before and after nutrient deprivation |
11.55 |
|
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation |
11.55 |
|
Pharmacologic inhibition of STAT5 in AML |
11.41 |
|
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. |
11.36 |
|
LIN28A modulates splicing and gene expression programs in breast cancer cells |
11.3 |
|
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] |
11.3 |
|
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins |
11.25 |
|
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma |
11.25 |
|
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression |
11.24 |
|
Patient-derived luminal breast cancer xenografts with progestins |
11.24 |
|
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins |
11.24 |
|
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells |
11.2 |
|
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone |
11.15 |
|
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 |
11.1 |
|
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells |
11.1 |
|
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages |
11.04 |
|
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) |
11.04 |
|
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells |
11.03 |
|
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] |
11.01 |
|
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations |
11.01 |
|
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development |
10.99 |
|
AMPK signaling for naïve pluripotency |
10.94 |
|
AMPK signaling for naïve pluripotency [Hs] |
10.94 |
|
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis |
10.94 |
|
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells |
10.93 |
|
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq |
10.91 |
|
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) |
10.89 |
|
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. |
10.86 |
|
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma |
10.84 |
|
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) |
10.84 |
|
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients |
10.83 |
|
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains |
10.74 |
|
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s |
10.7 |
|
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) |
10.61 |
|
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease |
10.56 |
|
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) |
10.56 |
|
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis |
10.45 |
|
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs |
10.44 |
|
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls |
10.43 |
|
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls |
10.43 |
|
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells |
10.42 |
|
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells |
10.4 |
|
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib |
10.35 |
|
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors |
10.34 |
|
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] |
10.25 |
|
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition |
10.25 |
|
N6-methyladenine DNA Modification in Glioblastoma |
10.19 |
|
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] |
10.19 |
|
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging |
10.18 |
|
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc |
10.18 |
|
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells |
10.08 |
|
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal |
10.05 |
|
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells |
9.99 |
|
Total RNA-seq in ALL-SIL upon TLX1 knockdown |
9.98 |
|
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) |
9.98 |
|
Cerebellar differentiation in Ataxia-Telangiectasia |
9.96 |
|
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation |
9.94 |
|
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] |
9.94 |
|
The m 6 A-methylase complex recruits TREX and regulates mRNA export. |
9.9 |
|
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation |
9.89 |
|
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells |
9.76 |
|
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] |
9.75 |
|
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis |
9.75 |
|
Mediator kinase inhibition further activates super-enhancer-associated genes in AML |
9.71 |
|
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. |
9.71 |
|
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated |
9.71 |
|
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism |
9.69 |
|
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells |
9.69 |
|
MYCi361 regulates MYC target genes |
9.65 |
|
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance |
9.61 |
|
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo |
9.6 |
|
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion |
9.56 |
|
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] |
9.52 |
|
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes |
9.51 |
|
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression |
9.5 |
|
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation |
9.47 |
|
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 |
9.43 |
|
Gene expression analysis upon mtDNA depletion |
9.31 |
|
Gene expression analysis upon mtDNA depletion [RNA-seq] |
9.31 |
|
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 |
9.26 |
|
Landscape and variation of RNA secondary structure across the human transcriptome |
9.24 |
|
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells |
9.22 |
|
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression |
9.22 |
|
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses |
9.16 |
|
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) |
9.14 |
|
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels |
9.11 |
|
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. |
9.11 |
|
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines |
9.1 |
|
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] |
9.09 |
|
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs |
9.08 |
|
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells |
9.04 |
|
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector |
9.02 |
|
Effect of PBK knockdown on C4-2 cell transcriptome |
9.01 |
|
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment |
8.99 |
|
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival |
8.9 |
|
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction |
8.88 |
|
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq |
8.86 |
|
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression |
8.84 |
|
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells |
8.82 |
|
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response |
8.78 |
|
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA |
8.74 |
|
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] |
8.73 |
|
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells |
8.73 |
|
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression |
8.72 |
|
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death |
8.71 |
|
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) |
8.71 |
|
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells |
8.7 |
|
Active translatome profiling with RiboLace in MCF7 cells |
8.68 |
|
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion |
8.67 |
|
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control |
8.66 |
|
Transcriptome analysis of CNS leukemia |
8.66 |
|
RNA-seq analysis of primary patient samples to characterize the CNS leukemia |
8.66 |
|
Novel Targeting of Transcription and Metabolism in Glioblastoma |
8.64 |
|
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells |
8.64 |
|
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts |
8.62 |
|
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation |
8.57 |
|
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis |
8.56 |
|
Stem and effector CD8 T-cells from human cancers |
8.54 |
|
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] |
8.53 |
|
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer |
8.48 |
|
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] |
8.44 |
|
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs |
8.44 |
|
Generation and persistence of human tissue-resident memory T cells in lung transplantation |
8.42 |
|
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS |
8.31 |
|
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex |
8.28 |
|
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin |
8.25 |
|
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function |
8.23 |
|
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China |
8.13 |
|
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] |
8.12 |
|
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation |
8.12 |
|
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells |
8.09 |
|
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome |
8.07 |
|
RNA-seq of SOX5 overexpressing primary human neuronal progenitors |
7.96 |
|
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA |
7.87 |
|
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation |
7.84 |
|
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) |
7.84 |
|
RNA-sequencing of human peripheral blood mononuclear cells (PB MNCs) and induced neural progenitor cells derived from PB MNCs |
7.83 |
|
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture |
7.83 |
|
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) |
7.74 |
|
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria |
7.7 |
|
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network |
7.65 |
|
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 |
7.6 |
|
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) |
7.59 |
|
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state |
7.53 |
|
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells |
7.53 |
|
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown |
7.41 |
|
EGR1-controlled transcriptome of T HESCs |
7.4 |
|
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide |
7.38 |
|
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells |
7.33 |
|
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] |
7.3 |
|
Hypoxic transcriptome of SQ20B human head and neck cancer cells |
7.27 |
|
Searching for target genes of miR-508/509/506/514 in HCT116 cells |
7.25 |
|
LncRNA expression profiling of ischemic stroke patients |
7.24 |
|
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus |
7.23 |
|
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells |
7.21 |
|
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells |
7.16 |
|
Induced DNA demethylation, genome instability and transcription |
7.16 |
|
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] |
7.15 |
|
BBBomics - Human Blood Brain Barrier Transcriptomics Hub |
7.15 |
|
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 |
7.11 |
|
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations |
7.09 |
|
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition |
7.05 |
|
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] |
7.05 |
|
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs |
7.03 |
|
Gene expression changes after LOC550643 silencing |
7.01 |
|
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells |
6.94 |
|
The cohesin release factor WAPL restricts chromatin loop extension. |
6.93 |
|
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] |
6.93 |
|
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] |
6.93 |
|
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice |
6.89 |
|
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation |
6.78 |
|
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells |
6.72 |
|
Transcriptomes of human monocytes after ex vivo exposure to uric acid |
6.64 |
|
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down |
6.63 |
|
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes |
6.61 |
|
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. |
6.57 |
|
The comparison of high-throughput single-cell RNA-seq methods |
6.53 |
|
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes |
6.53 |
|
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis |
6.52 |
|
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies |
6.52 |
|
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] |
6.43 |
|
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers |
6.41 |
|
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways |
6.41 |
|
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] |
6.34 |
|
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer |
6.34 |
|
Gene expressions of H9s in different culture systems |
6.32 |
|
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells |
6.32 |
|
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 |
6.31 |
|
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound |
6.3 |
|
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness |
6.28 |
|
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis |
6.23 |
|
RNA-seq of naive and primed ES cells (NHSM) |
6.21 |
|
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] |
6.2 |
|
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest |
6.19 |
|
naive T cell heterogeneity after neonatal thymectomy |
6.13 |
|
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone |
6.04 |
|
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells |
6.01 |
|
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression |
5.99 |
|
Anti-inflammatory effect of indoleacrylic acid (IA) |
5.98 |
|
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate |
5.98 |
|
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells |
5.96 |
|
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control |
5.93 |
|
KLF6-dependent transcription in renal cancer cells |
5.9 |
|
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms |
5.8 |
|
Defective structural RNA processing in relapsing-remitting multiple sclerosis |
5.71 |
|
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor |
5.71 |
|
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia |
5.69 |
|
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors |
5.69 |
|
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions |
5.62 |
|
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer |
5.57 |
|
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p |
5.56 |
|
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells |
5.54 |
|
Effect of BMP inhibition or stimulation of primary human keratinocytes |
5.52 |
|
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. |
5.52 |
|
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure |
5.52 |
|
Transcriptomic analysis of the role of the integrin a6b4 in detached cells |
5.52 |
|
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state |
5.49 |
|
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] |
5.48 |
|
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells |
5.47 |
|
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) |
5.47 |
|
Generation of KRAS signatures using immortalized isogenic lung cells. |
5.36 |
|
NAPRT activation of macrophages |
5.31 |
|
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes |
5.29 |
|
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance |
5.28 |
|
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells |
5.25 |
|
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity |
5.17 |
|
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity |
5.08 |
|
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) |
5.06 |
|
RNA-seq of RKO cells with cTAZ KO or putback |
5.03 |
|
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma |
5.0 |
|
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients |
4.98 |
|
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection |
4.72 |
|
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) |
4.69 |
|
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation |
4.69 |
|
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles |
4.63 |
|
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector |
4.62 |
|
Solid phase chemistry to covalently and reversibly capture thiolated RNA |
4.62 |
|
Transcriptional profiling of CD45RO+CD57+CD4+ T cells |
4.4 |
|
MARCKS and lnc-MARCKS act as inflammation regulators |
4.39 |
|
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes |
4.36 |
|
Transcriptome analysis of peripheral blood monocytes |
4.35 |
|
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] |
4.28 |
|
Dissecting neural differentiation regulatory networks through epigenetic footprinting |
4.25 |
|
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases |
4.24 |
|
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro |
4.22 |
|
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias |
4.22 |
|
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells |
4.17 |
|
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) |
4.14 |
|
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) |
4.09 |
|
CD74 role in transcription regulation |
4.09 |
|
CD74 role in transcription regulation [RNA-seq] |
4.09 |
|
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively |
4.0 |
|
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region |
3.91 |
|
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression |
3.85 |
|
STRIPAK directs PP2A activity to promote oncogenic transformation |
3.81 |
|
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] |
3.73 |
|
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers |
3.71 |
|
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] |
3.71 |
|
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) |
3.7 |
|
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. |
3.65 |
|
Molecular Criteria for Defining the Naive Human Pluripotent State |
3.61 |
|
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles |
3.52 |
|
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) |
3.52 |
|
Transcriptome analysis of SKI knock-out in HL60 cells |
3.51 |
|
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 |
3.51 |
|
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells |
3.5 |
|
miR-93 Targets in Human Endothelial Cells |
3.47 |
|
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor |
3.46 |
|
Thyroid State Regulates Gene Expression in Human Whole Blood Cells |
3.42 |
|
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells |
3.42 |
|
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells |
3.4 |
|
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells |
3.36 |
|
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data |
3.33 |
|
Effects of transcription on genome - nuclear lamina interactions |
3.33 |
|
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo |
3.32 |
|
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] |
3.32 |
|
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity |
3.31 |
|
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer |
3.26 |
|
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. |
3.26 |
|
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels |
3.12 |
|
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation |
3.03 |
|
Copper Regulation of HIF-1 Transcription Activity |
2.94 |
|
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] |
2.94 |
|
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site |
2.93 |
|
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 |
2.87 |
|
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones |
2.87 |
|
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer |
2.86 |
|
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection |
2.83 |
|
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. |
2.77 |
|
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells |
2.74 |
|
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs |
2.73 |
|
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT |
2.72 |
|
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer |
2.71 |
|
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits |
2.7 |
|
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells |
2.7 |
|
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression |
2.7 |
|
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II |
2.69 |
|
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. |
2.69 |
|
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation |
2.68 |
|
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles |
2.68 |
|
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p |
2.66 |
|
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq |
2.59 |
|
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade |
2.57 |
|
Frailty in middle age is associated with race-specific changes to the transcriptome. |
2.53 |
|
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation |
2.52 |
|
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] |
2.5 |
|
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment |
2.5 |
|
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells |
2.48 |
|
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function |
2.45 |
|
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection |
2.41 |
|
Generation and functional characterization of MDSC-like cells |
2.37 |
|
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes |
2.27 |
|
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 |
2.2 |
|
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] |
2.19 |
|
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins |
2.17 |
|
Transcriptomes in healthy and CHB fetal hearts |
2.09 |
|
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium |
2.08 |
|
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] |
2.06 |
|
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 |
2.06 |
|
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) |
2.03 |
|
A Unique Epigenomic Landscape Defines Human Erythropoiesis |
2.03 |
|
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 |
1.91 |
|
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers |
1.86 |
|
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) |
1.86 |
|
Aneuploidy triggers an immune response |
1.84 |
|
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants |
1.83 |
|
Identification of differentially expressed genes between senescence and senescence bypass cells |
1.81 |
|
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures |
1.78 |
|
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module |
1.77 |
|
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line |
1.77 |
|
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) |
1.77 |
|
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. |
1.77 |
|
AUF-1 affected genes in human skin cells |
1.76 |
|
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] |
1.71 |
|
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO |
1.71 |
|
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma |
1.64 |
|
The role of the Calcium-Sensing receptor in colorectal cancer |
1.63 |
|
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) |
1.61 |
|
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis |
1.58 |
|
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] |
1.57 |
|
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock |
1.57 |
|
MYCL and EP400 are required for Max and MCPyV mediated gene activation |
1.54 |
|
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 |
1.53 |
|
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes |
1.46 |
|
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML |
1.3 |
|
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] |
1.3 |
|
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown |
1.26 |
|
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown |
1.26 |
|
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] |
1.18 |
|
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells |
1.12 |
|
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo |
1.08 |
|
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] |
1.08 |
|
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis |
1.07 |
|
WNT signaling memory is required for ACTIVIN to function as a morphogen |
1.05 |
|
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq |
1.02 |
|
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 |
1.02 |
|
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) |
0.99 |
|
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program |
0.99 |
|
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics |
0.96 |
|
Expression analysis of the TAF1 syndrome |
0.95 |
|
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage |
0.95 |
|
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells |
0.88 |
|
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity |
0.86 |
|
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML |
0.85 |
|
Gene expression changes due to PARP knockdown in human cells |
0.81 |
|
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program |
0.8 |
|
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans |
0.79 |
|
Osmostress induced changes of chromatin architecture and transcription in mammalian cells |
0.7 |
|
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] |
0.7 |
|
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. |
0.64 |
|
FOXO1 is an oncogenic mediator in AML1-ETO leukemia |
0.62 |
|
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia |
0.59 |
|
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells |
0.53 |
|
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells |
0.49 |
|
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions |
0.4 |
|
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 |
0.37 |
|
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome |
0.37 |
|
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells |
0.35 |
|
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes |
0.32 |
|
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes |
0.27 |
|
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity |
0.25 |
|
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons |
0.25 |
|
Induction of Cardiomyocyte Proliferation [pz-822_human] |
0.24 |
|
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration |
0.24 |
|
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line |
0.22 |
|
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors |
0.21 |
|
In situ CAPTURE of chromatin interactions by biotinylated dCas9 |
0.2 |
|
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs |
0.2 |
|
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome |
0.18 |
|
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness |
0.15 |
|
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly |
0.14 |
|
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] |
0.13 |
|
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome |
0.11 |
|
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer |
0.09 |
|
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment |
0.06 |
|
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. |
0.01 |